Oncolytics Biotech Inc. (NASDAQ:ONCY) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Patricia S Andrews Other companies: Geron Corporation (Director · Since at least Mar 25, 2026); Crescent Biopharma, Inc. (Director · Jun 9, 2017 – May 1, 2024 · Past); Incyte Corporation (Chief Commercial Officer · Oct 21, 2008 – Jan 19, 2012 · Past) | Director · Since at least Jan 1, 2026 |
| Bernd R. Seizinger Other companies: Aprea Therapeutics, Inc. (Director · Since at least Oct 2, 2019); Aptose Biosciences Inc (Director · Sep 13, 2022 – Feb 5, 2024 · Past) | Director · Since at least Jan 1, 2026 |
| James Parsons Other companies: DiaMedica Therapeutics Inc. (Chairman of the Board · Since at least Dec 6, 2018); Trillium Therapeutics Inc (Chief Financial Officer · Jan 1, 2021 – Nov 17, 2021 · Past) | Director · Since at least Jan 1, 2026 |
| Jonathan Rigby Other companies: BioPlus Acquisition Corp (Chief Business Officer, Director · Dec 2, 2021 – Dec 2, 2021 · Past); SteadyMed Ltd (President and CEO, Director · Dec 28, 2017 – Aug 30, 2018 · Past) | Director · Since at least Jan 1, 2026 |
| Wayne Pisano Other companies: Altimmune, Inc. (Director · Since at least Aug 30, 2018); Provention Bio Inc (Director · Jul 3, 2018 – Apr 27, 2023 · Past) | Director · Since at least Jun 26, 2025 |
| Andrew Aromando Other companies: Ambrx Biopharma Inc. (Chief Operating Officer · Apr 28, 2023 – Mar 7, 2024 · Past) | Chief Business Officer · Since at least Jun 30, 2025 |
| John McAdory Other companies: CG Oncology, Inc. (EVP of Strategy and Operations · Jan 14, 2026 – Nov 5, 2026 · Past) | Chief Operating Officer · Since at least Jun 1, 2026 |
| Allison Hagerman | Chief Technology Officer · Since at least Nov 5, 2026 |
| Allison Hagerman | Chief Technology Officer · Since at least Jan 1, 2026 |
| Angela Holtham | Director · Since at least Jan 1, 2026 |
| Angela Holtham | Director · Since at least Nov 4, 2026 |
| Deborah M. Brown | Director · Since at least Jan 1, 2026 |
| Jared Kelly | Chief Executive Officer & Director · Since at least Jan 1, 2026 |
| Jon Patton | Director of Investor Relations & Communication · Since at least Oct 27, 2026 |
| Kirk Look | Chief Financial Officer · Since at least Nov 5, 2026 |
| Pat Andrews | Director · Since at least Nov 5, 2026 |
| Steve Glover | Director · Since at least Jun 2, 2026 |
| Thomas C. Heineman | Chief Medical Officer · Since at least Jan 1, 2026 |